Use of coxiella bacteria to treat autoimmune disease
US6790450B1 · kind B1 · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1999 |
| Grant date | Sep 14, 2004 |
| Priority date | — |
| Expiry date | Mar 5, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic compositions including a species of Coxiella or one or more antigenic components therefrom or analogous or homologous components thereof are disclosed. These compositions are useful in preventing, inhibiting, delaying onset of or otherwise ameliorating the effects of an autoimmune disease in a mammal, particularly insulin-dependent diabetes mellitus (IDDM). They arm also useful in prolonging survival of islet tissue transplanted into a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.